5-((4-(Diethylcarbamoyl)phenyl)amino)-5-oxopentanoic acid, 97%, 250mg

N-(5-Azido-2-nitrobenzoyloxy)succinimide, 97.0%, 25mg

Isopropyl palmitate, min. 90%, for synthesis, 1 l, plastic packaging.

(S)-2-Amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoic acid hydrochloride, 95.0%, 250mg

(1-Methyl-piperidin-4-yl)-acetic acid, 95.0%, 1g

H-D-Arg(NO2)-OMe HCl, 95.0%, 10g

5-Cyclopropyl-3-phenyl-[1,2,4]oxadiazole, 95.0%, 1g

5-Chloro-7-(trifluoromethyl)imidazo[1,5-a]pyridine, 98%, 250mg

(4,5-Dimethyl-thiazol-2-yl)-hydrazine Hydrochloride, 95.0%, 5g

Ethyl 2-chloro-5-fluoropyrimidine-4-carboxylate, 97%, 5g

Triisopropoxy(methyl)titanium, 1M in THF, 1.0 M in THF, 10g

(2,2-DIFLUORO-HEXAHYDRO-1H-PYRROLIZIN-7A-YL)METHANOL, 95%, 5g

1-(tert-Butyl) 2-methyl (R)-2,5-dihydro-1H-pyrrole-1,2-dicarboxylate, 97%, 1g